A61K 35/745
Bifidobacteria
A61K35/745 (Bifidobacteria) appears on 972 US grants and 2,081 published applications in this corpus.
Search patents in A61K- Granted patents
- 972
- Published applications
- 2,081
- Assignees
- 756
- Inventors
- 3,261
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 1 | 0 |
| 2001 | 6 | 2 |
| 2002 | 7 | 15 |
| 2003 | 5 | 24 |
| 2004 | 9 | 39 |
| 2005 | 11 | 33 |
| 2006 | 11 | 36 |
| 2007 | 11 | 32 |
| 2008 | 4 | 33 |
| 2009 | 5 | 50 |
| 2010 | 15 | 56 |
| 2011 | 20 | 51 |
| 2012 | 19 | 72 |
| 2013 | 32 | 64 |
| 2014 | 39 | 76 |
| 2015 | 46 | 82 |
| 2016 | 52 | 103 |
| 2017 | 64 | 97 |
| 2018 | 52 | 95 |
| 2019 | 54 | 127 |
| 2020 | 59 | 141 |
| 2021 | 68 | 159 |
| 2022 | 78 | 163 |
| 2023 | 85 | 148 |
| 2024 | 72 | 149 |
| 2025 | 65 | 138 |
| 2026 | 56 | 96 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation6 Oct 2026US 12,751,980 B2Jiangnan University
- Oral and intestinal health products6 Oct 2026US 12,751,985 B2
- Probiotics compositions and method of using the same to enhance growth and social function in children29 Sep 2026US 12,746,262 B2The General Hospital Corporation
- Probiotics compositions and method of using the same to enhance growth and social function in children29 Sep 2026US 12,746,264 B2The General Hospital Corporation
- Synergistic blends of probiotics expressing improved beneficial activity for human host favourably interacting with food, particularly baby food22 Sep 2026US 12,740,583 B2Coree S.R.L.
- Probiotic-fortified, high-protein food product and method of making same8 Oct 2026US 2026/0305659 A1
- Microbiome-based GABA Cream with Chondroitin Sulfate Transdermal Delivery System8 Oct 2026US 2026/0306531 A1
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306563 A1Societe des Produits Nestle S. A.
- Mixture of hmos and b. infantis8 Oct 2026US 2026/0306564 A1Societe des Produits Nestle S. A.
- Lacto-n-fucopentaose and b. infantis to protect from enteric pathogens1 Oct 2026US 2026/0294943 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Synergistic bacterial compositions and methods of production and use thereof242US 9,028,841 B2Seres Health, Inc. · 2015
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Compositions and methods239US 9,011,834 B1Seres Health, Inc. · 2015
- Method for treatment of idiopathic inflammatory bowel disease (IIBD)229US 5,599,795 A1997
- Pet food product containing probiotics145US 5,968,569 ANestec S. A. · 1999